RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Bristol-Myers Squibb Stocks 2024

Bristol-Myers Squibb Stocks

2.08 B

Bristol-Myers Squibb Dividend yield

5.1 %

Ticker

BMY

ISIN

US1101221083

WKN

850501

In 2024, Bristol-Myers Squibb had 2.08 B outstanding stocks, a 0% change from the 2.08 B stocks in the previous year.

The Bristol-Myers Squibb Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e2.08
2028e2.08
2027e2.08
2026e2.08
2025e2.08
2024e2.08
20232.08
20222.15
20212.25
20202.26
20191.71
20181.64
20171.65
20161.68
20151.68
20141.67
20131.66
20121.69
20111.72
20101.73
20091.98
20082
20071.98
20061.96
20051.98
20041.98

Bristol-Myers Squibb Aktienanalyse

What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide. Bristol-Myers Squibb ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Bristol-Myers Squibb's Shares Outstanding

Bristol-Myers Squibb's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Bristol-Myers Squibb’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Bristol-Myers Squibb’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Bristol-Myers Squibb’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Bristol-Myers Squibb Stock

How many stocks are there of Bristol-Myers Squibb?

The current number of stocks of Bristol-Myers Squibb is 2.08 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Bristol-Myers Squibb are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Bristol-Myers Squibb evolved in recent years?

The number of shares of Bristol-Myers Squibb has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Bristol-Myers Squibb as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Bristol-Myers Squibb?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Bristol-Myers Squibb pay?

Over the past 12 months, Bristol-Myers Squibb paid a dividend of 2.28 USD . This corresponds to a dividend yield of about 5.1 %. For the coming 12 months, Bristol-Myers Squibb is expected to pay a dividend of 2.43 USD.

What is the dividend yield of Bristol-Myers Squibb?

The current dividend yield of Bristol-Myers Squibb is 5.1 %.

When does Bristol-Myers Squibb pay dividends?

Bristol-Myers Squibb pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Bristol-Myers Squibb?

Bristol-Myers Squibb paid dividends every year for the past 26 years.

What is the dividend of Bristol-Myers Squibb?

For the upcoming 12 months, dividends amounting to 2.43 USD are expected. This corresponds to a dividend yield of 5.43 %.

In which sector is Bristol-Myers Squibb located?

Bristol-Myers Squibb is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bristol-Myers Squibb kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bristol-Myers Squibb from 5/1/2024 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 4/4/2024.

When did Bristol-Myers Squibb pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Bristol-Myers Squibb in the year 2023?

In the year 2023, Bristol-Myers Squibb distributed 2.16 USD as dividends.

In which currency does Bristol-Myers Squibb pay out the dividend?

The dividends of Bristol-Myers Squibb are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bristol-Myers Squibb stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Bristol-Myers Squibb

Our stock analysis for Bristol-Myers Squibb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bristol-Myers Squibb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.